Tenon Medical Q4 revenue $808k (+192% YoY); FY gross profit turns positive at $1.2M

Tenon Medical, Inc.

Q4 revenue $808k, up 192% YoY; FY revenue $2.9M, up 324% YoY.
FY gross profit $1.2M vs. gross loss ($641k) in 2022; Q4 gross margin 69%.
Surgical procedures using Catamaran System increased 312% in FY 2023.
Subsequent to year end: issued ~$3.85M Series A Preferred, raising $2.6M, repaid $1.25M secured debt.
Net loss $15.6M for FY 2023 vs. $18.9M in 2022; operating loss $15.7M.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Tenon Medical, Inc. reported the fourth quarter and full year ended December 31, 2023 results: revenue $808,000 in the fourth quarter of 2023.

Period: the fourth quarter and full year ended December 31, 2023
Revenue: $808,000 in the fourth quarter of 2023
Result: reported results

Exact text from the filing

On March 12, 2024, Tenon Medical, Inc. (the “Company”) issued a press release announcing its earnings for the fourth quarter ended December 31, 2023 and the fiscal year ended December 31, 2023.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Tenon Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-022411

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.